These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20019161)

  • 1. Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?
    Roth RA; Ganey PE
    J Pharmacol Exp Ther; 2010 Mar; 332(3):692-7. PubMed ID: 20019161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
    Shaw PJ; Hopfensperger MJ; Ganey PE; Roth RA
    Toxicol Sci; 2007 Nov; 100(1):259-66. PubMed ID: 17709330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.
    Shaw PJ; Ganey PE; Roth RA
    Toxicol Sci; 2010 Nov; 118(1):7-18. PubMed ID: 20538741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).
    Iasella CJ; Johnson HJ; Dunn MA
    Clin Liver Dis; 2017 Feb; 21(1):73-87. PubMed ID: 27842776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.
    Deng X; Luyendyk JP; Ganey PE; Roth RA
    Pharmacol Rev; 2009 Sep; 61(3):262-82. PubMed ID: 19805476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.
    Cosgrove BD; King BM; Hasan MA; Alexopoulos LG; Farazi PA; Hendriks BS; Griffith LG; Sorger PK; Tidor B; Xu JJ; Lauffenburger DA
    Toxicol Appl Pharmacol; 2009 Jun; 237(3):317-30. PubMed ID: 19362101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity.
    Maddox JF; Amuzie CJ; Li M; Newport SW; Sparkenbaugh E; Cuff CF; Pestka JJ; Cantor GH; Roth RA; Ganey PE
    J Toxicol Environ Health A; 2010; 73(1):58-73. PubMed ID: 19953420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation.
    Deng X; Stachlewitz RF; Liguori MJ; Blomme EA; Waring JF; Luyendyk JP; Maddox JF; Ganey PE; Roth RA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1191-9. PubMed ID: 16990511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multipathway phosphoproteomic signaling network model of idiosyncratic drug- and inflammatory cytokine-induced toxicity in human hepatocytes.
    Cosgrove BD; Alexopoulos LG; Saez-Rodriguez J; Griffith LG; Lauffenburger DA
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():5452-5. PubMed ID: 19964679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry.
    Saab L; Peluso J; Muller CD; Ubeaud-Sequier G
    Cytometry A; 2013 Apr; 83(4):403-8. PubMed ID: 23401306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver.
    Piñeiro-Carrero VM; Piñeiro EO
    Pediatrics; 2004 Apr; 113(4 Suppl):1097-106. PubMed ID: 15060205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats.
    Luyendyk JP; Maddox JF; Cosma GN; Ganey PE; Cockerell GL; Roth RA
    J Pharmacol Exp Ther; 2003 Oct; 307(1):9-16. PubMed ID: 12893837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metabolism in drug-induced idiosyncratic hepatotoxicity.
    Walgren JL; Mitchell MD; Thompson DC
    Crit Rev Toxicol; 2005; 35(4):325-61. PubMed ID: 15989140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system.
    Zou W; Devi SS; Sparkenbaugh E; Younis HS; Roth RA; Ganey PE
    Toxicol Sci; 2009 Mar; 108(1):184-93. PubMed ID: 19074762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of immune-mediated liver injury.
    Adams DH; Ju C; Ramaiah SK; Uetrecht J; Jaeschke H
    Toxicol Sci; 2010 Jun; 115(2):307-21. PubMed ID: 20071422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils.
    Waring JF; Liguori MJ; Luyendyk JP; Maddox JF; Ganey PE; Stachlewitz RF; North C; Blomme EA; Roth RA
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1080-7. PubMed ID: 16299187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of Idiosyncratic Drug-Induced Liver Injury.
    Yokoi T; Oda S
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():247-268. PubMed ID: 32976738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
    Mosedale M; Watkins PB
    Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.